terça-feira, 6 de outubro de 2026
PesquisarExplore
pt.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 6, 2026

Stocks Retreat Amid Inflation Fears and Weak US Jobs

View original at nasdaq.com
Stocks Retreat Amid Inflation Fears and Weak US Jobs The S&P 500 Index ($SPX) (SPY) today is down -0.95%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -1.00%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.76%…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Excluding the Magnificent Seven megacap technology stocks, Q4 earnings are expected to increase by 4.6%

    80% confidence

  • All Gulf energy exporters would shut down production within weeks, driving crude oil prices to $150 per barrel

    80% confidence

  • US doesn't want to negotiate an end to the war with Iran and there will be no deal with Iran except unconditional surrender

    80% confidence

  • S&P earnings growth is expected to climb by 8.4% in Q4, marking the tenth consecutive quarter of year-over-year growth

    80% confidence

  • Real-time risk premium for crude oil is $18 per barrel, corresponding to estimate of impact from six-week full halt to tanker traffic in Strait of Hormuz

    80% confidence

  • Year-over-year revenue growth rate will accelerate each quarter throughout fiscal 2027

    80% confidence

  • The Iran war is unlikely to cause sustained inflation, which is why the Fed looks at core prices excluding energy as a better predictor of future inflation

    80% confidence

  • The war in the Middle East could bring down the economies of the world

    80% confidence

  • Ships sailing through Strait of Hormuz could be at risk from missiles or rogue drones

    80% confidence

Citado nestas reportagens da Via News

O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Stocks Retreat Amid Inflation Fears and Weak US Jobs — Source | Via News | pt.VIA.NEWS